Stockscreener 앱 받기
25.18
1.41%
0.35
시간 외 거래:
25.18
전일 마감가:
$24.83
열려 있는:
$24.99
하루 거래량:
893.39K
Relative Volume:
0.54
시가총액:
$1.43B
수익:
$308.05M
순이익/손실:
$-95.57M
주가수익비율:
-14.64
EPS:
-1.72
순현금흐름:
$-58.34M
1주 성능:
+9.34%
1개월 성능:
+0.24%
6개월 성능:
-20.34%
1년 성능:
-53.72%
1일 변동 폭
$24.25
$25.27
1주일 범위
$21.28
$26.13
52주 변동 폭
$19.35
$66.85
Procept Biorobotics Corp Stock (PRCT) Company Profile
명칭
Procept Biorobotics Corp
전화
(650) 232-9832
주소
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
25.18 | 1.41B | 308.05M | -95.57M | -58.34M | -1.72 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-06 | 개시 | Robert W. Baird | Neutral |
| 2026-02-26 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2026-02-26 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-12-12 | 개시 | UBS | Buy |
| 2025-12-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-09-02 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-07-09 | 개시 | Stephens | Overweight |
| 2025-07-07 | 개시 | Oppenheimer | Perform |
| 2024-12-02 | 개시 | Morgan Stanley | Overweight |
| 2024-11-14 | 개시 | Jefferies | Hold |
| 2023-08-11 | 개시 | Piper Sandler | Overweight |
| 2023-05-31 | 개시 | William Blair | Outperform |
| 2022-10-31 | 개시 | BTIG Research | Neutral |
| 2022-10-25 | 개시 | Truist | Buy |
| 2022-09-02 | 개시 | Wells Fargo | Overweight |
| 2022-07-15 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | 개시 | B. Riley Securities | Buy |
| 2021-10-11 | 개시 | BofA Securities | Buy |
| 2021-10-11 | 개시 | Cowen | Outperform |
| 2021-10-11 | 개시 | Goldman | Neutral |
| 2021-10-11 | 개시 | Guggenheim | Buy |
| 2021-10-11 | 개시 | SVB Leerink | Outperform |
모두보기
Procept Biorobotics Corp 주식(PRCT)의 최신 뉴스
Does Stronger Aquablation Tailwinds And Reaffirmed 2026 Guidance Change The Bull Case For PROCEPT (PRCT)? - Sahm
PRCT SEC FilingsProcept Biorobotics Corp 10-K, 10-Q, 8-K Forms - Stock Titan
How The PROCEPT BioRobotics (PRCT) Investment Story Is Shifting After Q4 Miss And Guidance Reset - Yahoo Finance
Latest PRCT NewsPROCEPT BioRobotics Corporation Announces C... - Stock Titan
Assessing PROCEPT BioRobotics (PRCT) Valuation After Mixed Q1 2026 Results And Share Price Weakness - Sahm
PROCEPT BioRobotics Corp Q1 2026 Financial Results and SEC 10-Q Filing Highlights - Minichart
PROCEPT BioRobotics (PRCT)’s Growth Narrative Improves Following Aquablation Upgrade and HYDROS Launch - Insider Monkey
PRCT Stock Price, Quote & Chart | PROCEPT BIOROBOTICS CORP (NASDAQ:PRCT) - ChartMill
PROCEPT BioRobotics Q1 Loss Deepens To US$0.56 EPS And Tests Bullish Revenue Narratives - simplywall.st
Procept Biorobotics Charts Growth Amid Profit Pressures - TipRanks
PROCEPT BioRobotics (PRCT) CTO reports share and option stakes - Stock Titan
PROCEPT BioRobotics (NASDAQ: PRCT) Q1 2026 revenue rises 20% - Stock Titan
PROCEPT BioRobotics to Attend Three Upcoming Investor Conferences in May & June - Moomoo
PROCEPT BioRobotics schedules 3 investor conference appearances - Stock Titan
10 Best Robotics Stocks to Buy Under $30 - Insider Monkey
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Gap UpStill a Buy? - MarketBeat
Vanguard (NASDAQ: PRCT) holds 2.82M shares, a 5% stake - Stock Titan
Procept projects $390M-$410M 2026 revenue as Hydros pricing guides $450K-$460K for rest of year - MSN
Procept BioRobotics price target raised to $35 from $28 at Piper Sandler - TipRanks
PROCEPT BioRobotics Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Earnings Call Summary | PROCEPT BioRobotics(PRCT.US) Q1 2026 Earnings Conference - Moomoo
PROCEPT BioRobotics (NASDAQ:PRCT) Posts Quarterly Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat
PROCEPT BioRobotics Q1 Earnings Call Highlights - Yahoo Finance
PROCEPT BioRobotics Corporation (PRCT) reports Q1 loss, tops revenue estimates - MSN
Procept BioRobotics reports Q1 EPS (56c), consensus (55c) - TipRanks
Earnings call transcript: Procept Biorobotics Q1 2026 beats EPS expectations By Investing.com - Investing.com South Africa
Earnings call transcript: Procept Biorobotics Q1 2026 beats EPS expectations - Investing.com
12,200 U.S. procedures put PROCEPT BioRobotics' systems to work in Q1 - Stock Titan
PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
PROCEPT BioRobotics Corporation (PRCT) Stock Rises on Q1 2026 Earnings - Quiver Quantitative
Earnings Flash (PRCT) PROCEPT BioRobotics Corporation Reports Q1 Revenue $83.1M, vs. FactSet Est of $80.5M - marketscreener.com
PROCEPT BioRobotics (Nasdaq: PRCT) grows Q1 2026 revenue 20% but stays loss-making - Stock Titan
PROCEPT BioRobotics Reports First Quarter 2026 Financial Results - The Manila Times
PROCEPT BioRobotics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Procept Biorobotics in the spotlight as Q1 earnings test turnaround - Investing.com UK
Procept Biorobotics in the spotlight as Q1 earnings test turnaround By Investing.com - Investing.com Australia
Robotics Stocks To Follow TodayApril 28th - MarketBeat
PROCEPT BioRobotics (PRCT) Price Target Decreased by 16.88% to 55.27 - MSN
PROCEPT BioRobotics (PRCT) price target decreased by 37.60% to 33.58 - MSN
59,200 Shares in PROCEPT BioRobotics Corporation $PRCT Bought by B. Metzler seel. Sohn & Co. AG - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) Rating Increased to Sell at Wall Street Zen - MarketBeat
PROCEPT BioRobotics (NASDAQ: PRCT) executive discloses initial stock and option stakes - Stock Titan
Chicago Capital Doubles Down on PROCEPT BioRobotics, Adds $27 Million in Stock - The Motley Fool
Procept BioRobotics stock rating reiterated at Buy by TD Cowen - Investing.com Australia
PRCT (PROCEPT BioRobotics Corporation) posts 37.2 percent year over year revenue growth, shares fall 4.48 percent on steep EPS miss.Product Revenue - UBND thành phố Hải Phòng
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Securities Fraud Investigation Into PROCEPT BioRobotics Corporati - The National Law Review
Procept Biorobotics Corp (PRCT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.41%
0.93%
자본화:
|
볼륨(24시간):